Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy

Clinics

Volumn 69, Issue 10, 2014, Pages 699-705

  De Lima, Patricia Azevedo ^a   De Brito Sampaio, Leticia Pereira ^a   Teixeira Damasceno, Nágila Raquel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ketogenic Diet; Ketone Bodies; Refractory Epilepsy

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIOGENIC AMINE; KETONE BODY; NEUROPROTECTIVE AGENT;

ADOLESCENT; CHILD; DIET THERAPY; EPILEPSY; HUMAN; KETOGENIC DIET; MEDICAL ILLUSTRATION; METABOLISM; PROCEDURES;

ADOLESCENT; BIOGENIC MONOAMINES; CHILD; EPILEPSY; HUMANS; KETOGENIC DIET; KETONE BODIES; MEDICAL ILLUSTRATION; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS;

EID: 84920402658     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2014(10)09     Document Type: Article

References (53)

1. Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist A, Blackford R, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2009;50(2):304-17, http://dx.doi.org/10.1111/j.1528-1167.2008.01765.x
2. Cendes F. Progressive hippocampal and extrahippocampal atrophy in drug resistant epilepsy. Curr Opin Neurol. 2005;18(2):173-7, http://dx.doi.org/10.1097/01.wco.0000162860.49842.90
3. Sutula TP, Hagen J, Pitkänen A. Do epileptic seizures damage the brain? Curr Opin Neurol. 2003;16(2):189-95, http://dx.doi.org/10.1097/00019052-200304000-00012
4. Wang H, Lin K. Ketogenic diet: An early option for epilepsy treatment, instead of a last choice only. Biomedical Journal. 2013;36(1):16, http://dx.doi.org/10.4103/2319-4170.107155
5. Wilder R. The effect of ketonemia on the course of epilepsy. Mayo Clinic Bulletin. 1921;2:307
6. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurology. 2008;7(6):500-6, http://dx.doi.org/10.1016/S1474-4422(08)70092-9
7. De Kinderen RJ, Lambrechts DA, Postulart D, Kessels AG, Hendriksen JG, Aldenkamp AP, et al. Research into the (Cost-) effectiveness of the ketogenic diet among children and adolescents with intractable epilepsy: design of a randomized controlled trial. BMC Neurology. 2011;11(1):10, http://dx.doi.org/10.1186/1471-2377-11-10
8. Hirano Y, Oguni H, Shiota M, Nishikawa A, Osawa M. Ketogenic diet therapy can improve ACTH-resistant West syndrome in Japan. Brain Dev. 2014
9. Pablos-Sánchez T, Oliveros-Leal L, Núñez-Enamorado N, CamachoSalas A, Moreno-Villares JM, Simón-De las Heras R. The use of the ketogenic diet as treatment for refractory epilepsy in the paediatric age. Rev Neurol. 2014;58(2):55-62
10. Lee PR, Kossoff EH. Dietary treatments for epilepsy: management guidelines for the general practitioner. Epilepsy & Behavior. 2011;21(2):115-21, http://dx.doi.org/10.1016/j.yebeh.2011.03.008
11. Sharma S, Jain P. The Modified Atkins Diet in Refractory Epilepsy. Epilepsy Res Treat. 2014;2014:404202
12. Kossoff EH. More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol. 2004;3(7):415-20, http://dx.doi.org/10.1016/S1474-4422(04)00807-5
13. Sharma S, Jain P, Gulati S, Sankhyan N, Agarwala A. Use of the Modified Atkins Diet in Lennox Gastaut Syndrome. J Child Neurol. 2014
14. Kossoff EH, Bosarge JL, Miranda MJ, Wiemer-Kruel A, Kang HC, Kim HD. Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet? Epilepsia. 2010;51(12):2496-9, http://dx.doi.org/10.1111/j.1528-1167.2010.02774.x
15. Ramm-Pettersen A, Nakken KO, Haavardsholm KC, Selmer KK. Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet. Epilepsy Behav. 2014;32:76-8, http://dx.doi.org/10.1016/j.yebeh.2014.01.003
16. Kim DW, Kang HC, Park JC, Kim HD. Benefits of thenonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics. 2004;114(6):1627-30, http://dx.doi.org/10.1542/peds.2004-1001
17. Masino SA, Rho JM. Mechanisms of ketogenic diet action. In: Noebls JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper’s Basic Mechanisms of the Epilepsies. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012
18. Freeman JM, Kossoff EH, Hartman AL. The ketogenic diet: one decade later. Pediatrics. 2007;119(3):535-43, http://dx.doi.org/10.1542/peds.2006-2447
19. Dahlin M, Månsson J-E, Å mark P. CSF levels of dopamine and serotonin, but not norepinephrine, metabolites are influenced by the ketogenic diet in children with epilepsy. Epilepsy Research. 2012;99(1):132-8, http://dx.doi.org/10.1016/j.eplepsyres.2011.11.003
20. Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Current Opinion in Neurology. 2012;25(2):173-8, http://dx.doi.org/10.1097/WCO.0b013e3283515e4a
21. McNally MA, Hartman AL. Ketone bodies in epilepsy. Journal of Neurochemistry.2012;121(1):28-35,http://dx.doi.org/10.1111/j.1471-4159.2012.07670.x
22. Prins ML. Cerebral metabolic adaptation and ketone metabolism after brain injury. Journal of Cerebral Blood Flow & Metabolism. 2008;28(1): 1-16, http://dx.doi.org/10.1038/sj.jcbfm.9600543
23. Klein P, Janousek J, Barber A, Weissberger R. Ketogenic diet treatment in adultswithrefractoryepilepsy. EpilepsyBehav.2010;19(4):575-79,http://dx.doi.org/10.1016/j.yebeh.2010.09.016
24. Fisher RS. Animal models of the epilepsies. Brain Res Brain Res Rev. 1989;14(3):245-78, http://dx.doi.org/10.1016/0165-0173(89)90003-9
25. Löscher W. Animal models of intractable epilepsy. Prog Neurobiol. 1997;53(2):239-58, http://dx.doi.org/10.1016/S0301-0082(97)00035-X
26. Gasior M, French A, Joy MT, Tang RS, Hartman AL, Rogawski MA. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1, 2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia. 2007;48(4):793-800, http://dx.doi.org/10.1111/j.1528-1167.2007.01026.x
27. Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC, Burnham WM. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Annals of Neurology. 2003;54(2):219-26, http://dx.doi.org/10.1002/ana.10634
28. Ruskin DN, Masino SA. The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy. Front Neurosci. 2012;6:33, http://dx.doi.org/10.3389/fnins.2012.00033
29. LaManna JC, Salem N, Puchowicz M, Erokwu B, Koppaka S, Flask C, Lee Z. Ketones suppress brain glucose consumption. Adv Exp Med Biol. 2009;645:301-6, http://dx.doi.org/10.1007/978-0-387-85998-9_45
30. Dahlin M, Elfving Å, Ungerstedt U, Å mark P. The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the CSF in children with refractory epilepsy. Epilepsy Res. 2005;64(3):115-25, http://dx.doi.org/10.1016/j.eplepsyres.2005.03.008
31. Neal E, Cross J. Efficacy of dietary treatments for epilepsy. J Hum Nutr Diet. 2010;23(2):113-9,http://dx.doi.org/10.1111/j.1365-277X.2010.01043.x
32. Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I. Brain amino acid metabolism and ketosis. J Neurosci Res. 2001;66(2):272-81, http://dx.doi.org/10.1002/jnr.1221
33. Suzuki Y, Takahashi H, Fukuda M, Hino H, Kobayashi K, Tanaka J, et al. b-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res. 2009;1268(1):17-23, http://dx.doi.org/10.1016/j.brainres.2009.02.074
34. Tanner GR, Lutas A, Martínez-François JR, Yellen G. Single KATP channel opening in response to action potential firing in mouse dentate granule neurons. J Neurosci. 2011;31(23):8689-96, http://dx.doi.org/10.1523/JNEUROSCI.5951-10.2011
35. Omote H, Miyaji T, Juge N, Moriyama Y. Vesicular neurotransmitter transporter: bioenergetics and regulation of glutamate transport. Biochemistry. 2011;50(25):5558-65, http://dx.doi.org/10.1021/bi200567k
36. Juge N, Gray JA, Omote H, Miyaji T, Inoue T, Hara C, et al. Metabolic controlofvesicular glutamate transportandrelease.Neuron.2010;68(1):99112, http://dx.doi.org/10.1016/j.neuron.2010.09.002.
37. Weinshenker D. The contribution of norepinephrine and orexigenic neuropeptides to the anticonvulsant effect of the ketogenic diet. Epilepsia. 2008;49(s8):104-7, http://dx.doi.org/10.1111/j.1528-1167.2008.01850.x
38. Martillotti J, Weinshenker D, Liles LC, Eagles DA. A ketogenic diet and knockout of the norepinephrine transporter both reduce seizure severity in mice. Epilepsy Res. 2006;68(3):207-11, http://dx.doi.org/10.1016/j.eplepsyres.2005.11.002
39. Masino SA, Kawamura M, Wasser CD, Pomeroy LT, Ruskin DN. Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. Curr Neuropharmacol. 2009;7(3)257-68
40. Fedele DE, Gouder N, Güttinger M, Gabernet L, Scheurer L, Rülicke T, et al. Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. Brain. 2005;128(10):2383-95, http://dx.doi.org/10.1093/brain/awh555
41. Masino SA, Li T, Theofilas P, Sandau US, Ruskin DN, Fredholm BB, et al. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Invest. 2011;121(7):2679-83, http://dx.doi.org/10.1172/JCI57813
42. Chuang YC. Mitochondrial dysfunction and oxidative stress in seizureinduced neuronal cell death. Acta Neurol Taiwan. 2010;19(1):3-15
43. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol. 2006;60(2):223-35, http://dx.doi.org/10.1002/ana.20899
44. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004;55(4):576-80, http://dx.doi.org/10.1002/ana.20062
45. Jarrett SG, Milder JB, Liang LP, Patel M. The ketogenic diet increases mitochondrial glutathione levels. J Neurochem. 2008;106(3):1044-51, http://dx.doi.org/10.1111/j.1471-4159.2008.05460.x
46. Maalouf M, Rho JM, Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 2009;59(2):293-315, http://dx.doi.org/10.1016/j.brainresrev.2008.09.002
47. Milder J, Patel M. Modulation of oxidative stress and mitochondrial function by the ketogenic diet. Epilepsy Res. 2012;100(3):295-303, http://dx.doi.org/10.1016/j.eplepsyres.2011.09.021
48. Yuen AW, Sander JW. Rationale for using intermittent calorie restriction as a dietary treatment for drug resistant epilepsy. Epilepsy Behav. 2014;33C:110-4, http://dx.doi.org/10.1016/j.yebeh.2014.02.026
49. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med. 2000;29(3-4):222-30, http://dx.doi.org/10.1016/S0891-5849(00)00317-8
50. Chuang YC, Lin JW, Chen SD, Lin TK, Liou CW, Lu CH, et al. Preservation of mitochondrial integrity and energy metabolism during experimental status epilepticus leads to neuronal apoptotic cell death in the hippocampus of the rat. Seizure. 2009;18(6):420-8, http://dx.doi.org/10.1016/j.seizure.2009.03.002
51. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med. 2004;37(12):1951-62, http://dx.doi.org/10.1016/j.freeradbiomed.2004.08.021
52. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 2001; 18(9):685-716, http://dx.doi.org/10.2165/00002512-200118090-00004
53. Maiese K, Chong ZZ, Shang YC, Wang S. mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol Med. 2013; 19(1):51-60, http://dx.doi.org/10.1016/j.molmed.2012.11.001.